Supplement Disclaimers Work Only For Substantiated Claims – NAD
This article was originally published in The Tan Sheet
Executive Summary
Express and implied claims for Neuracel's pain relief supplement are not supported by a mouse study and the firm’s offer to include a disclaimer on its website to qualify claims would not rectify the problem, the National Advertising Division says.
You may also be interested in...
FTC Brings Dot-Com Disclosure Guide To Social Media, Mobile Era
Revised online advertising disclosure guidelines detail FTC’s expectations for how advertisers should craft disclosures in the world of social media and mobile devices.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.